Monitoring the plasma concentration of ripretinib and its metabolites in Chinese patients with gastrointestinal stromal tumors in a real‐life setting
Year: 2025
Type: article
Language: en
Topic: Gastrointestinal Tumor Research and Treatment
Authors and affiliations:
raw_author_name: Qiang Zhang
raw_affiliation_strings: Department of General Surgery The First Affiliated Hospital of Nanjing Medical University  Nanjing Jiangsu China
Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Fengyuan Li
raw_affiliation_strings: Department of General Surgery The First Affiliated Hospital of Nanjing Medical University  Nanjing Jiangsu China
Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Feng Wang
raw_affiliation_strings: Department of General Surgery Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School  Nanjing Jiangsu China
Department of General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
raw_author_name: Yongjian Zhou
raw_affiliation_strings: Department of Gastric Cancer Surgery Fudan University Shanghai Cancer Center  Shanghai China
Department of General Surgery Fujian Medical University Union Hospital  Fuzhou Fujian China
Department of Oncology Shanghai Medical College Fudan University  Shanghai China
Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
raw_author_name: Haoran Qian
raw_affiliation_strings: Department of General Surgery Sir Run Run Shaw Hospital School of Medicine Zhejiang University  Hangzhou China
Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China
raw_author_name: Ming Wang
raw_affiliation_strings: Department of Gastrointestinal Surgery Renji Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China
Department of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
raw_author_name: Xin Wu
raw_affiliation_strings: Department of General Surgery Chinese PLA General Hospital  Beijing China
Department of General Surgery, Chinese PLA General Hospital, Beijing, China
raw_author_name: Ye Zhou
raw_affiliation_strings: Department of Gastric Cancer Surgery Fudan University Shanghai Cancer Center  Shanghai China
Department of General Surgery Fujian Medical University Union Hospital  Fuzhou Fujian China
Department of Oncology Shanghai Medical College Fudan University  Shanghai China
Department of Gastric Cancer Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
raw_author_name: Linsen Zhou
raw_affiliation_strings: Department of General Surgery Yancheng No. 1 People’s Hospital  Yancheng China
Department of General Surgery, Yancheng No. 1 People's Hospital, Yancheng, China
raw_author_name: Luning Sun
raw_affiliation_strings: Research Division of Clinical Pharmacology First Affiliated Hospital of Nanjing Medical University  Nanjing China
Research Division of Clinical Pharmacology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
raw_author_name: Yongqing Wang
raw_affiliation_strings: Research Division of Clinical Pharmacology First Affiliated Hospital of Nanjing Medical University  Nanjing China
Research Division of Clinical Pharmacology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
raw_author_name: Zekuan Xu
raw_affiliation_strings: Department of General Surgery The First Affiliated Hospital of Nanjing Medical University  Nanjing Jiangsu China
Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Xiaofeng Sun
raw_affiliation_strings: Department of Oncology The Affiliated Cancer Hospital of Nanjing Medical University  Nanjing Jiangsu China
Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Hao Xu
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine School of Public Health Nanjing Medical University  Nanjing China
Department of General Surgery The First Affiliated Hospital of Nanjing Medical University  Nanjing Jiangsu China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University  Nanjing China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, Nanjing, China
Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China